Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation

Selenium has strong antioxidant properties and diverse effects on the immune system. The aim of the study was to analyse the protective effect of selenium as a component of a kidney preservation solution on the prevention of ischemia-reperfusion injury of nephrons. The solution was modified by the a...

Full description

Bibliographic Details
Main Authors: Aneta Ostróżka-Cieślik, Barbara Dolińska, Florian Ryszka
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/16/3592
_version_ 1797559681054408704
author Aneta Ostróżka-Cieślik
Barbara Dolińska
Florian Ryszka
author_facet Aneta Ostróżka-Cieślik
Barbara Dolińska
Florian Ryszka
author_sort Aneta Ostróżka-Cieślik
collection DOAJ
description Selenium has strong antioxidant properties and diverse effects on the immune system. The aim of the study was to analyse the protective effect of selenium as a component of a kidney preservation solution on the prevention of ischemia-reperfusion injury of nephrons. The solution was modified by the addition of Se (1 µg/L), prolactin (0.1 µg/L) and Se with prolactin (1 µg/L Se + 0.1 µg/L PRL). The study used a model for storing isolated porcine kidneys in Biolasol<sup>®</sup> (modified Biolasol<sup>®</sup>), which minimizes ischemia-reperfusion injury of grafts. The introduction of Se<sup>4+</sup> ions at a dose of 1 µg/L into the Biolasol<sup>®</sup> preservation solution in the form of Na<sub>2</sub>SeO<sub>3</sub> caused an increase in the activity/concentration of the analysed biochemical parameters: aspartate transaminase, alanine transaminase, urea and protein. This suggests an adverse effect of Se<sup>4+</sup> on nephron function during ischemia-reperfusion. The best graft protection was obtained by using Biolasol<sup>®</sup> modified with the addition of selenium (IV) at a dose of 1 µg/L and prolactin at a concentration of 0.1 µg/L. We proposed the mechanism of prolactin action in the metabolic reduction of selenite (SO<sub>3</sub><sup>2−</sup>) during ischemia/reperfusion.
first_indexed 2024-03-10T17:48:46Z
format Article
id doaj.art-4d5cf786e6fb4d228cb2fbf4db0be8c2
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T17:48:46Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-4d5cf786e6fb4d228cb2fbf4db0be8c22023-11-20T09:25:01ZengMDPI AGMolecules1420-30492020-08-012516359210.3390/molecules25163592Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney TransplantationAneta Ostróżka-Cieślik0Barbara Dolińska1Florian Ryszka2Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Kasztanowa 3, 41-200 Sosnowiec, PolandDepartment of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Kasztanowa 3, 41-200 Sosnowiec, Poland“Biochefa” Pharmaceutical Research and Production Plant, Kasztanowa 3, 41-200 Sosnowiec, PolandSelenium has strong antioxidant properties and diverse effects on the immune system. The aim of the study was to analyse the protective effect of selenium as a component of a kidney preservation solution on the prevention of ischemia-reperfusion injury of nephrons. The solution was modified by the addition of Se (1 µg/L), prolactin (0.1 µg/L) and Se with prolactin (1 µg/L Se + 0.1 µg/L PRL). The study used a model for storing isolated porcine kidneys in Biolasol<sup>®</sup> (modified Biolasol<sup>®</sup>), which minimizes ischemia-reperfusion injury of grafts. The introduction of Se<sup>4+</sup> ions at a dose of 1 µg/L into the Biolasol<sup>®</sup> preservation solution in the form of Na<sub>2</sub>SeO<sub>3</sub> caused an increase in the activity/concentration of the analysed biochemical parameters: aspartate transaminase, alanine transaminase, urea and protein. This suggests an adverse effect of Se<sup>4+</sup> on nephron function during ischemia-reperfusion. The best graft protection was obtained by using Biolasol<sup>®</sup> modified with the addition of selenium (IV) at a dose of 1 µg/L and prolactin at a concentration of 0.1 µg/L. We proposed the mechanism of prolactin action in the metabolic reduction of selenite (SO<sub>3</sub><sup>2−</sup>) during ischemia/reperfusion.https://www.mdpi.com/1420-3049/25/16/3592seleniumprolactinorgan preservation solutionBiolasol<sup>®</sup>kidney transplantation
spellingShingle Aneta Ostróżka-Cieślik
Barbara Dolińska
Florian Ryszka
Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation
Molecules
selenium
prolactin
organ preservation solution
Biolasol<sup>®</sup>
kidney transplantation
title Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation
title_full Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation
title_fullStr Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation
title_full_unstemmed Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation
title_short Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation
title_sort therapeutic potential of selenium as a component of preservation solutions for kidney transplantation
topic selenium
prolactin
organ preservation solution
Biolasol<sup>®</sup>
kidney transplantation
url https://www.mdpi.com/1420-3049/25/16/3592
work_keys_str_mv AT anetaostrozkacieslik therapeuticpotentialofseleniumasacomponentofpreservationsolutionsforkidneytransplantation
AT barbaradolinska therapeuticpotentialofseleniumasacomponentofpreservationsolutionsforkidneytransplantation
AT florianryszka therapeuticpotentialofseleniumasacomponentofpreservationsolutionsforkidneytransplantation